Literature DB >> 31896621

Draft Genome Sequences of the Type Strains of Actinobacillus indolicus (46K2C) and Actinobacillus porcinus (NM319), Two NAD-Dependent Bacterial Species Found in the Respiratory Tract of Pigs.

Janine T Bossé1, Yanwen Li2, Roberto Fernandez Crespo2, Øystein Angen3, Matthew T G Holden4, Lucy A Weinert5, Duncan J Maskell5, Alexander W Tucker5, Brendan W Wren6, Andrew N Rycroft7, Paul R Langford.   

Abstract

We report here the draft genome sequences of the type strains of Actinobacillus indolicus (46K2C) and Actinobacillus porcinus (NM319). These NAD-dependent bacterial species are frequently found in the upper respiratory tract of pigs and are occasionally associated with lung pathology.
Copyright © 2020 Bossé et al.

Entities:  

Year:  2020        PMID: 31896621      PMCID: PMC6940273          DOI: 10.1128/MRA.00716-19

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

Bacteria belonging to the family Pasteurellaceae that inhabit the porcine respiratory tract and require NAD (also called the V factor) for growth include Actinobacillus pleuropneumoniae, Glaesserella parasuis (formerly Haemophilus parasuis), Actinobacillus indolicus, Actinobacillus porcinus, Actinobacillus minor, and a separate species tentatively designated “Actinobacillus porcitonsillarum,” which, although phenotypically more similar to A. pleuropneumoniae, is phylogenetically closer to A. minor (1–5). The first two species are important pathogens, whereas the latter four are considered commensals of the upper respiratory tract (1, 3, 6), though isolates of A. indolicus and A. porcinus, associated with lung pathology, have been identified (1). For A. pleuropneumoniae, there are two biotypes based on the requirement for NAD, with most isolates belonging to the NAD-dependent biovar 1 (7, 8). The phylogeny of the Pasteurellaceae is complicated, and there remain numerous species with uncertain taxonomic status (4, 9, 10). Whole-genome sequences, which can help clarify evolutionary relationships and the development of differential diagnostics, are available for all of the above-mentioned bacteria except A. indolicus and A. porcinus. We therefore chose to sequence the type strains, 46K2C and NM319, respectively, of these species. Both 46K2CT and NM319T were originally isolated from the upper respiratory tract of pigs in Denmark (11) and Canada (12), respectively. They were initially identified as Haemophilus taxons D and F, respectively, prior to their designation as the type strains of the newly assigned species in 1996 (1, 2). Strains 46K2CT and NM319T were obtained from the Culture Collection University of Gothenburg (CCUG 39029T and CCUG 38924T, respectively), stored frozen at −80°C in 25% glycerol, and minimally passaged (up to four times) on brain heart infusion agar (Difco) supplemented with 0.01% NAD prior to genomic DNA extraction using a FastDNA spin kit (MP Biomedicals), according to the manufacturer’s protocol for bacterial cells. Paired-end libraries were prepared from 500 ng of genomic DNA, as previously described (13), using the modified Illumina protocol developed by Quail et al. (14) for sequencing at the Wellcome Sanger Institute (Hinxton, UK) on an Illumina HiSeq 2000 analyzer for 75 cycles. Draft genome sequences were assembled de novo using a previously reported pipeline (15). Briefly, the 2 × 76-bp paired reads were used to create multiple assemblies for each species’ genome using Velvet v1.2 (16) and VelvetOptimiser v2.2.5 (http://bioinformatics.net.au/software.velvetoptimiser.shtml). For each genome, the assembly with the best N50 value was further improved by scaffolding contigs using SSPACE (17), with any gaps filled by GapFiller (18). Automated annotation was performed for both genome assemblies using Prokka v1.5 (19). Default parameters were used for all software programs. The draft genome of A. indolicus 46K2CT was assembled from 2,031,716 total reads, with an average quality score of 37.9, into 22 contigs (N50, 183,245; L50, 4), with a total length of 2,103,350 bases. This sequence encodes 1,956 predicted proteins and has a G+C content of 40.1%, which is higher than the 35.5% originally determined (2) but lower than the value of 42.6% calculated by Kuhnert and Korczak based on the G+C content of selected genes (20). The draft genome of A. porcinus NM319T was assembled from 1,733,818 reads, with an average quality score of 37.8, into 29 contigs (N50, 182,117; L50, 5), with a total length of 2,280,774 bases. This sequence encodes 2,095 predicted proteins and has a G+C content of 41.1%, which is similar to values (41.4% and 41.6%) previously reported for this strain (2, 20). The availability of the draft genome sequences of the type strains of A. indolicus and A. porcinus will facilitate differentiation of these species from other NAD-dependent bacteria found in the porcine respiratory tract and contribute to the understanding of Pasteurellaceae phylogeny and host interactive biology.

Data availability.

The draft genome assemblies for A. indolicus 46K2CT and A. porcinus NM319T have been deposited in the European Nucleotide Archive (ENA) under BioProject number PRJEB31492. Raw sequence reads have been deposited in the ENA under accession numbers ERS134282 and ERS134597, respectively. The ENA accession numbers for the assembled contigs are GCA_901764975 (CABFKH010000001 through CABFKH010000022) and GCA_901764995 (CAAGST010000001 through CAAGST010000029), respectively.
  20 in total

1.  Phylogeny of the family Pasteurellaceae based on rpoB sequences.

Authors:  Bożena Korczak; Henrik Christensen; Stefan Emler; Joachim Frey; Peter Kuhnert
Journal:  Int J Syst Evol Microbiol       Date:  2004-07       Impact factor: 2.747

Review 2.  Update on Actinobacillus pleuropneumoniae-knowledge, gaps and challenges.

Authors:  E L Sassu; J T Bossé; T J Tobias; M Gottschalk; P R Langford; I Hennig-Pauka
Journal:  Transbound Emerg Dis       Date:  2017-10-30       Impact factor: 5.005

3.  Non-pathogenic Actinobacillus isolates antigenically and biochemically similar to Actinobacillus pleuropneumoniae: a novel species?

Authors:  M Gottschalk; A Broes; K R Mittal; M Kobisch; P Kuhnert; A Lebrun; J Frey
Journal:  Vet Microbiol       Date:  2003-03-20       Impact factor: 3.293

4.  Actinobacillus minor sp. nov., Actinobacillus porcinus sp. nov., and Actinobacillus indolicus sp. nov., three new V factor-dependent species from the respiratory tract of pigs.

Authors:  K Møller; V Fussing; P A Grimont; B J Paster; F E Dewhirst; M Kilian
Journal:  Int J Syst Bacteriol       Date:  1996-10

5.  Phylogenomic analysis of Haemophilus parasuis and proposed reclassification to Glaesserella parasuis, gen. nov., comb. nov.

Authors:  Allan Dickerman; Aloka B Bandara; Thomas J Inzana
Journal:  Int J Syst Evol Microbiol       Date:  2020-01       Impact factor: 2.747

6.  Evaluation of a selective medium for isolation of Haemophilus pleuropneumoniae.

Authors:  K A Gilbride; S Rosendal
Journal:  Can J Comp Med       Date:  1983-10

7.  Toward almost closed genomes with GapFiller.

Authors:  Marten Boetzer; Walter Pirovano
Journal:  Genome Biol       Date:  2012-06-25       Impact factor: 13.583

8.  Phylogenomic and molecular demarcation of the core members of the polyphyletic pasteurellaceae genera actinobacillus, haemophilus, and pasteurella.

Authors:  Sohail Naushad; Mobolaji Adeolu; Nisha Goel; Bijendra Khadka; Aqeel Al-Dahwi; Radhey S Gupta
Journal:  Int J Genomics       Date:  2015-03-03       Impact factor: 2.326

9.  Robust high-throughput prokaryote de novo assembly and improvement pipeline for Illumina data.

Authors:  Andrew J Page; Nishadi De Silva; Martin Hunt; Michael A Quail; Julian Parkhill; Simon R Harris; Thomas D Otto; Jacqueline A Keane
Journal:  Microb Genom       Date:  2016-08-25

10.  A large genome center's improvements to the Illumina sequencing system.

Authors:  Michael A Quail; Iwanka Kozarewa; Frances Smith; Aylwyn Scally; Philip J Stephens; Richard Durbin; Harold Swerdlow; Daniel J Turner
Journal:  Nat Methods       Date:  2008-12       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.